Carbetocin is a drug medication used to prevent excessive bleeding (postpartum hemorrhage) after giving birth, particularly following cesarean section. The drug is an analog of oxytocin and works similar to that of oxytocin. It is administered by injection in the vein or muscle. A single dose of this drug act as 16 hours intravenous oxytocin infusion regarding the increase in uterine tone.
MARKET SCOPE
The "Global Carbetocin Injection Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the carbetocin injection market with detailed market segmentation by type, end user, and geography. The report provides key statistics on the market status of the leading carbetocin injection market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global carbetocin injection market is segmented into original drug and generic drug.
- On the basis of end-users, the market is bifurcated into hospitals, clinics and other.
MARKET DYNAMICS
Drivers:
- Increasing incidences of postpartum hemorrhage and increasing birth rate drive the carbetocin injection market growth.
- Growing research & development activities and the introduction of technologically advanced products fuel market growth.
- Advanced facilities in hospital infrastructure in developing countries propel market growth.
Restraints:
- Repeated or overdosage of the drug causes various problems.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The carbetocin injection market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the carbetocin injection market in these regions.
IMPACT OF COVID-19 ON CARBETOCIN INJECTION MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the pandemic, the worldwide pharmaceutical market was affected. The worldwide lockdown, supply and production chain disruption, and business shutdown have impacted the market's growth. Non-essential surgeries were postponed, and only emergency procedures were allowed to be carried out. Hence, the above-mentioned factors affected the development of the carbetocin market in the pandemic period.
MARKET PLAYERS
The report covers key developments in the carbetocin injection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from carbetocin injection market are anticipated to have lucrative growth opportunities in the future with the rising demand for carbetocin injection in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the carbetocin injection market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Ferring Pharmaceuticals
- Hybio Pharmaceutical
- Pfizer
- Beacon Pharmaceuticals Ltd.
- Chengdu Shengnuo Biotechnology
- Tibet Aim Pharm Inc (Aim Pharm)
- SGPharma
- Smokin Joe
- MDA INC.
- Taj Pharmaceuticals